Formulation Development Article Archives | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology

Sort

Processa Pharmaceuticals Assigned License for Compound CTP-499
Thursday, March 22, 2018
Processa Pharmaceuticals announced that the company has been assigned the license for CTP-499 upon Promet's exercising of the exclusive option to ... read more
Processa Pharmaceuticals Expands NGC-Cap Program into Advanced or Metastatic Breast Cancer
Monday, January 22, 2024
Processa Pharmaceuticals, Inc. plans to expand the development of Next Generation Capecitabine (“NGC-Cap”) into the treatment of advanced or ... read more
Processa Pharmaceuticals Receives FDA Clearance of PCS-499
Tuesday, October 02, 2018
Processa announced the FDA has granted clearance to proceed with a Phase 2 clinical trial of PCS-499 in patients with Necrobiosis Lipoidica under a ... read more
Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In Necrobiosis Lipoidica From The Food And Drug Administration (FDA)
Friday, June 22, 2018

Processa Pharmaceuticals, Inc. (OTC: PCSA) a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of
... read more
Sponsored by gChem
Tuesday, October 21, 2025
Long-acting injectables and topical formulations require excipients that provide stability and enhance absorption. PROCIPIENT^® delivers these benefits... read more
Product Development and Manufacturing Challenges for Combination Products
Friday, February 16, 2018
Creating and delivering safe and effective products that reliably meet our customers’ needs, to improve patients’ health and quality of life, is ... read more
Product Mispackaging Results in Nationwide Recall
Wednesday, July 02, 2025
Sandoz is initiating a voluntary recall of one lot of Cefazolin for Injection, USP, 1 gram per vial. This single lot is being recalled due to a ... read more
Product Quest Manufacturing Recalls CVS Health 12 Hour Sinus Relief Nasal Mist
Wednesday, August 08, 2018
Product Quest Manufacturing is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid, to the ... read more
Product Quest Manufacturing Recalls All Nasal Products, Baby Oral Gels
Friday, August 31, 2018
Product Quest Manufacturing has announced a voluntary recall of Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist due to a finding of ... read more
Product Real Time Release for the Microbial Critical Quality Attribute Using QbD Approach
Saturday, March 01, 2008
The objective of this document is to propose an achievement of product microbial Real Time Release (RTR) based on process and product understanding. ... read more
Sponsored by Nelson Labs
Thursday, February 13, 2025
Product sterility testing ensures the safety of products by detecting microbial contamination. Per the traditional compendial methodology described in... read more
Product Temperature Monitoring and Control via Thermal Imaging during Continuous Freeze-Drying of Pharmaceutical Unit Doses
Tuesday, August 27, 2019
Following the current trends in drug development, the focus of pharmaceutical companies is shifting from small molecule compounds towards biological ... read more
Production Challenges for Complex Biologics: Fusion Proteins
Sunday, February 05, 2017
In the last two years five novel fusion proteins were approved by the FDA, raising the total number of marketed therapeutic fusion proteins to ... read more
ProductLife Group to Merge with Pharma D&S Group
Wednesday, June 07, 2023
ProductLife Group (PLG), a global provider of regulatory, vigilance and quality management services for the pharmaceutical, biotech and medtech ... read more
Profluent and Lilly Sign Multi-Program AI Partnership to Develop Recombinase-Based Genetic Medicines
Tuesday, April 28, 2026
Profluent announced a multi-program strategic research collaboration with Eli Lilly and Company to develop and commercialize custom, site-specific ... read more